Ohcanbohtosat - Jean‐Christophe Tille

  • Čájehuvvo 1 - 12 / 12
Aiddostahte ozu
  1. 1
    Estrogen receptor-α immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis

    Estrogen receptor-α immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis Dahkki Nicola Pluchino, Ramanaiah Mamillapalli, Jean‐Marie Wenger, Lauriane Ramyead, Panagiotis Drakopoulos, Jean‐Christophe Tille, Hugh S. Taylor

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours

    First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours Dahkki Ilse Van der Auwera, Yihai Cao, Jean‐Christophe Tille, Michael S. Pepper, David G. Jackson, Stephen B. Fox, Adrian L. Harris, Luc Dirix, Peter Vermeulen

    Almmustuhtton 2006
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C

    Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C Dahkki Kris Persaud, Jean‐Christophe Tille, Meilin Liu, Zhenping Zhu, Xenia Jimenez, Daniel S. Pereira, Hua‐Quan Miao, Laura Brennan, Larry Witte, Michael S. Pepper, Bronislaw Pytowski

    Almmustuhtton 2004
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    <i>ERBB2</i> mutations associated with solid variant of high-grade invasive lobular breast carcinomas

    <i>ERBB2</i> mutations associated with solid variant of high-grade invasive lobular breast carcinomas Dahkki Gabrielle Deniziaut, Jean Christophe Tille, François‐Clément Bidard, Sophie Vacher, Anne Schnitzler, Walid Chemlali, Laurence Trémoulet, Laetitia Fuhrmann, Paul Cottu, Roman Rouzier, Ivan Bièche, Anne Vincent‐Salomon

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma

    Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma Dahkki Jean‐Christophe Tille, André Filipe Vieira, C. Saint-Martin, Lounes Djerroudi, Laëtitia Furhmann, François‐Clément Bidard, Youlia Kirova, A. Tardivon, Fabien Reyal, Matthieu Carton, Anne Vincent‐Salomon

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues

    Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues Dahkki Carine Steiner, Jean‐Christophe Tille, Jens Lamerz, Sabine Kux van Geijtenbeek, Thomas McKee, Miro Venturi, Laura Rubbia‐Brandt, Denis F. Hochstrasser, Paul Cutler, Pierre Lescuyer, Axel Ducret

    Almmustuhtton 2015
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast

    Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast Dahkki Marion Lavigne, Emmanuelle Menet, Jean‐Christophe Tille, Marick Laé, Laetitia Fuhrmann, Claire Bonneau, Gabrielle Deniziaut, Samia Melaabi, Charlotte K.Y. Ng, Caterina Marchiò, Roman Rouzier, Ivan Bièche, Anne Vincent‐Salomon

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

    Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes Dahkki Solène De Talhouet, Julien Péron, Aurélie Vuilleumier, Alex Friedlaender, Valeria Viassolo, Aurélie Ayme, Alexandre Bodmer, Isabelle Treilleux, Noémie Lang, Jean Christophe Tille, Pierre O. Chappuis, Adrien Buisson, Sophie Giraud, Christine Lasset, Valérie Bonadona, Olivier Trédan, Sana Intidhar Labidi‐Galy

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

    Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes Dahkki Hervé Bonnefoi, Gaëtan MacGrogan, Coralie Poncet, Richard Iggo, Fanny Pommeret, Thomas Grellety, Denis Larsimont, Véronique Becette, Olivier Kerdraon, Frédéric Bibeau, Jean‐Pierre Ghnassia, Jean‐Michel Picquenot, Jeremy Thomas, Jean‐Christophe Tille, Leen Slaets, Alexandre Bodmer, Jonas Bergh, David Cameron

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    High grade serous ovarian carcinomas originate in the fallopian tube

    High grade serous ovarian carcinomas originate in the fallopian tube Dahkki Sana Intidhar Labidi‐Galy, Eniko Papp, Dorothy Hallberg, Noushin Niknafs, Vilmos Adleff, Michaël Noë, Rohit Bhattacharya, Marián Novak, Siân Jones, Jillian Phallen, Carolyn Hruban, Michelle S. Hirsch, Douglas I. Lin, Lauren E. Schwartz, Cécile L. Maire, Jean‐Christophe Tille, Michaela Bowden, A. Ayhan, Laura D. Wood, Robert B. Scharpf, Robert J. Kurman, Tian-Li Wang, Ie‐Ming Shih, Rachel Karchin, Ronny Drapkin, Victor E. Velculescu

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours

    H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours Dahkki Diego Dibitetto, Martin Liptay, Francesca Vivalda, Hülya Doğan, Ewa Gogola, Martín González Fernández, Alexandra A. Duarte, Jonas Schmid, Morgane Decollogny, Paola Francica, Sara Przetocka, Stephen T. Durant, Josep V. Forment, Ismar Klebic, Myriam Siffert, Roebi de Bruijn, Arne Nedergaard Kousholt, Nicole A. Marti, Martina Dettwiler, Claus Storgaard Sørensen, Jean‐Christophe Tille, Manuela Undurraga, Sana Intidhar Labidi‐Galy, Massimo Lopes, Alessandro A. Sartori, Jos Jonkers, Sven Rottenberg

    Almmustuhtton 2024
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)

    Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions) Dahkki Constanze Elfgen, Cornelia Leo, R. Huch, Simone Muenst, Noemi Schmidt, Cecily Quinn, Sorcha McNally, P. J. van Diest, Ritse M. Mann, Zsuzsanna Bagó-Horváth, Maria Bernathova, Peter Regitnig, Michael Fuchsjäger, Daniela Schwegler-Guggemos, Martina Maranta, Sabine Zehbe, Christoph Tausch, Uwe Güth, Eva Maria Fallenberg, Simone Schrading, Ashutosh Kothari, Martin Sonnenschein, G Kampmann, Janina Kulka, Jean‐Christophe Tille, Meike Körner, Thomas Decker, Sigurd Lax, Martin Daniaux, Vesna Bjelic‐Radisic, Stephanie Strobl, Rosaria Condorelli, Michael Gnant, Zsuzsanna Varga

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: